BHVN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
126.4M
+1.2%
124.9M
-4.2%
130.4M
-8.6%
142.7M
-15.7%
169.4M
R&D
101.8M
+1.0%
100.8M
-2.9%
103.8M
-14.9%
121.9M
-13.6%
141.2M
SG&A
24.6M
+2.0%
24.1M
-9.5%
26.6M
+28.0%
20.8M
-26.3%
28.2M
Operating Income
-126420000
-1.2%
-124899000
+4.2%
-130428000
+8.6%
-142734000
+15.7%
-169382000
EBITDA
-124196000
-1.3%
-122640000
+4.2%
-128062000
+8.6%
-140161000
+15.7%
-166257000
Net Income
-129279000
+5.8%
-137311000
-5.2%
-130532000
+10.3%
-145555000
+16.1%
-173443000
EPS (Basic)
$-0.86
+5.5%
$-0.91
-3.4%
$-0.88
+27.3%
$-1.21
+26.2%
$-1.64
EPS (Diluted)
$-0.86
+5.5%
$-0.91
-3.4%
$-0.88
+27.3%
$-1.21
+26.2%
$-1.64
Shares (Diluted)
151.0M
+0.3%
150.6M
+2.0%
147.6M
+22.6%
120.4M
+13.8%
105.8M
Biohaven (BHVN) — Financials